Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate prehydration before CTPA to prevent contrast-induced nephropathy
NL-OMON38375Phase 3Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sodium bicarbonate in contrast-induced nephropathy (CIN) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Mean increase in serum creatinine. Started Nov 2009; status: active, not recruiting.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NL-OMON38375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38375.